Jun 28, 2023

The Next Generation: Aisha Naamani

Mar 14, 2023

The Next Generation: Hector Gonzalez Alvarez

Jan 12, 2023

Drug Discovery scientist wants to speed up development of new cancer therapeutics

Sep 27, 2022

The Next Generation: Mahmoud Noureldin

Aug 29, 2022

Previously overlooked proteins are a potential source for a new class of cancer killing drugs

Nov 25, 2020

Cancer research through COVID: A drug discovery student's perspective

Jul 21, 2020

OICR Drug Discovery awarded for COVID-19 research

Jun 17, 2020

Inside OICR’s Drug Discovery Lab: A graduate student’s unique collaborative experience

Jun 16, 2020

OICR joins European consortium to ‘enable and unlock biology in the open’

Jun 11, 2020

Community-driven initiative finds new potential avenue of ovarian cancer treatment

May 20, 2020

Study points to common protein duo as a new therapeutic target for several cancer types

Feb 27, 2020

Innovative drug screening method finds new promising molecules to treat aggressive lung cancers

Nov 01, 2019

Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR

Jul 24, 2019

OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies

May 21, 2019

Activating the immune system to fight cancer

Mar 08, 2019

Moving in vivo: A case of navigating through translational research roadblocks

Feb 21, 2019

OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects

Jan 29, 2019

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment

Sep 13, 2018

FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants

Sep 04, 2018

Meet our students - 2018

Aug 22, 2018

Meet the researchers: Ratheesh Subramaniam

Jul 31, 2018

Can an open drug discovery model find a solution for rare brain cancers in children?

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Mar 22, 2017

FACIT Announces Investment in Propellon Therapeutics

Feb 10, 2017

How chemical probes can boost cancer research

Dec 06, 2016

Congratulations to Ahmed Aman on another successful Movember fundraiser

Sep 19, 2016

Open resource: How we’re making our research resources more accessible to the community

Aug 18, 2016

Registration now open for the Mark Ernsting Drug Discovery Memorial Lecture

Jul 26, 2016

OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community

Jul 18, 2016

Save the date: Mark Ernsting Drug Discovery Memorial Lecture on September 22, 2016

Jun 21, 2016

Ask an expert: How are new cancer drugs created?

May 01, 2016

OICR invests in early-stage Ontario oncology drug development

Jan 07, 2016

Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario

Dec 29, 2015

OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Oct 14, 2015

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Sep 03, 2015

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research